Related references
Note: Only part of the references are listed.Alveolar Epithelial Type II Cells as Drivers of Lung Fibrosis in Idiopathic Pulmonary Fibrosis
Tanyalak Parimon et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Classical and Nonclassical Intercellular Communication in Senescence and Ageing
Juan Antonio Fafian-Labora et al.
TRENDS IN CELL BIOLOGY (2020)
Progression of fibrosing interstitial lung disease
Alyson W. Wong et al.
RESPIRATORY RESEARCH (2020)
Quercetin in Idiopathic Pulmonary Fibrosis: Another Brick in the Senolytic Wall
Jacobo Sellares et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2019)
Developmental pathways in the pathogenesis of lung fibrosis
Diptiman Chanda et al.
MOLECULAR ASPECTS OF MEDICINE (2019)
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
K. R. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Loss of PTEN induces lung fibrosis via alveolar epithelial cell senescence depending on NF-κB activation
Yaqiong Tian et al.
AGING CELL (2019)
Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
Jamie N. Justice et al.
EBIOMEDICINE (2019)
The role of HDAC2 in cigarette smoke-induced airway inflammation in a murine model of asthma and the effect of intervention with roxithromycin
Mengling Xia et al.
JOURNAL OF ASTHMA (2018)
Impact of Lung Function Decline on Health-Related Quality of Life in Patients with Idiopathic Pulmonary Fibrosis (IPF)
M. Kreuter et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Azithromycin and Roxithromycin define a new family of senolytic drugs that target senescent human fibroblasts
Bela Ozsvari et al.
AGING-US (2018)
Nintedanib with Add-on Pirfenidone in Idiopathic Pulmonary Fibrosis Results of the INJOURNEY Trial
Carlo Vancheri et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo
Mareike Lehmann et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
The Clinical Potential of Senolytic Drugs
James L. Kirkland et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2017)
Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease
Ana L. Mora et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Cellular senescence mediates fibrotic pulmonary disease
Marissa J. Schafer et al.
NATURE COMMUNICATIONS (2017)
Azithromycin attenuates myofibroblast differentiation and lung fibrosis development through proteasomal degradation of NOX4
Kazuya Tsubouchi et al.
AUTOPHAGY (2017)
Epithelial cell senescence: an adaptive response to pre-carcinogenic stresses?
Corinne Abbadie et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors
Yi Zhu et al.
AGING CELL (2016)
Roxithromycin inhibits VEGF-induced human airway smooth muscle cell proliferation: Opportunities for the treatment of asthma
Qing-Mei Pei et al.
EXPERIMENTAL CELL RESEARCH (2016)
Telomere dysfunction in alveolar epithelial cells causes lung remodeling and fibrosis
Ram P. Naikawadi et al.
JCI INSIGHT (2016)
The Achilles' heel of senescent cells: from transcriptome to senolytic drugs
Yi Zhu et al.
AGING CELL (2015)
Effect of Low-Dose, Long-Term Roxithromycin on Airway Inflammation and Remodeling of Stable Noncystic Fibrosis Bronchiectasis
Jifeng Liu et al.
MEDIATORS OF INFLAMMATION (2014)
Reversal of Persistent Fibrosis in Aging by Targeting Nox4-Nrf2 Redox Imbalance
Louise Hecker et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Gene expression profiles reveal molecular mechanisms involved in the progression and resolution of bleomycin-induced lung fibrosis
Sandra Cabrera et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2013)
Abnormal Lung Aging in Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis
Rosa Faner et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Pulmonary fibrosis: patterns and Perpetrators
Paul W. Noble et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis
Brett Ley et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
An Official ATS/ERSARS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Idiopathic pulmonary fibrosis
Talmadge E. King et al.
LANCET (2011)
The effect of macrolides on myofibroblast differentiation and collagen production in nasal polyp-derived fibroblasts
Hyo-Hyun Park et al.
AMERICAN JOURNAL OF RHINOLOGY & ALLERGY (2010)
NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFβ1-induced fibroblast differentiation into myofibroblasts
Nadia Amara et al.
THORAX (2010)
Senescence of activated stellate cells limits liver fibrosis
Valery Krizhanovsky et al.
CELL (2008)
The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis?
Antje Moeller et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix
Kevin K. Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Release of biologically active TGF-β1 by alveolar epithelial cells results in pulmonary fibrosis
YD Xu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2003)
Myofibroblast differentiation by transforming growth factor-β1 is dependent on cell adhesion and integrin signaling via focal adhesion kinase
VJ Thannickal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Share Paper
